6YTI
CLK1 bound with ETH1610 (Cpd 17)
Summary for 6YTI
| Entry DOI | 10.2210/pdb6yti/pdb |
| Descriptor | Dual specificity protein kinase CLK1, 1,2-ETHANEDIOL, methyl 9-[(2-fluoranyl-4-methoxy-phenyl)amino]-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate, ... (4 entities in total) |
| Functional Keywords | inhibitor, complex, clk1, structural genomics, structural genomics consortium, sgc, transferase |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 40213.18 |
| Authors | Schroeder, M.,Chaikuad, A.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2020-04-24, release date: 2020-07-15, Last modification date: 2024-01-24) |
| Primary citation | Schroder, M.,Bullock, A.N.,Fedorov, O.,Bracher, F.,Chaikuad, A.,Knapp, S. DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity. J.Med.Chem., 63:10224-10234, 2020 Cited by PubMed: 32787076DOI: 10.1021/acs.jmedchem.0c00898 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.4 Å) |
Structure validation
Download full validation report
